ARTICLE | Company News
Theradiag, Miraca deal
December 21, 2015 8:00 AM UTC
Theradiag granted Miraca’s Miraca Life Sciences subsidiary exclusive, U.S. rights to develop and commercialize Lisa Tracker therapeutic drug monitoring assays for use in irritable bowel disease (IBD) ...